6000! That's the number of associates in the BioMedical Research (BR). This division is the innovation engine of Novartis, focusing on powerful new technologies that have the potential to help produce therapeutic breakthroughs for patients!
Based on our understanding of cancer at the molecular, cellular and organismal levels, Translational Clinical Oncology or TCO will design and execute innovative exploratory clinical trials in order to develop the next generation of highly effective therapeutics that transform the lives of patients with cancer. This role is to provide strategic medical guidance and lead the development of experimental oncology agents in the TCO portfolio, from the Phase of preclinical development, continuing through clinical First in Human and Phase 1b / 2 studies.
Your responsibilities will include but are not limited to :
- Acts as a clinical leader responsible for assigned global clinical program(s) -driving medical strategy implementation and operational deliverables for investigational products in a defined therapeutic area
- Ensure effective cross-functional communications to align with global strategy and leads the development of clinical sections of trial and program level regulatory documents
- Acts as the medical expert, engages interactions with external stakeholders (e.g., regulatory authorities, key opinion leaders, data monitoring committees, advisory boards etc.) and internal NVS stakeholders
- Contributes to medical / scientific training of relevant Novartis stakeholders. May serve as speaker for medical / scientific training -May serve on or lead global initiatives (e.g., process improvement, training, SOP development, other Clinical Development line function initiatives)
- Experience leading early and / or late phase Oncology clinical programs with radiopharmaceuticals from the pharma / biotech industry plus credible experience from an academic medical center. In case of no industry experience then significant academic experience in Radio Oncology with credible PI / co-PI clinical study leadership
- Track record of significant contributions to your field over time, creating new concepts and seeking out new clinical discovery opportunities / approaches